Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 3Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 35Breast Neoplasms 27Prostatic Neoplasms 22Stomach Neoplasms 13Squamous Cell Carcinoma of Head and Neck 12Neoplasms 10Lung Neoplasms 10Urinary Bladder Neoplasms 8Head and Neck Neoplasms 8Triple Negative Breast Neoplasms 7Neoplasm Metastasis 7Carcinoma, Squamous Cell 6Non-Muscle Invasive Bladder Neoplasms 5Nasopharyngeal Carcinoma 5Carcinoma, Transitional Cell 5Adenocarcinoma 5Oropharyngeal Neoplasms 4Sarcoma 3Prostatic Neoplasms, Castration-Resistant 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Ovarian Neoplasms 3Metastatic Castration-resistant Prostate Cancer 3HER2-positive Breast Cancer 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Anatomic Stage I Breast Cancer AJCC v8 3Vaccinia 2Recurrence 2Peritoneal Neoplasms 2Metastatic Castration-Resistant Prostate Cancer 2

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 7Cisplatin 7Surgical Procedures, Operative 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Platinum 3Chemoradiotherapy 3Cetuximab 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3Radiotherapy 2Radiation 2Interviews as Topic 2Docetaxel 2toripalimab 1sacituzumab govitecan 1merphos 1ipatasertib 1cabozantinib 1X-Rays 1Tretinoin 1Surveys and Questionnaires 1Standard of Care 1Radiotherapy, Image-Guided 1Radiosurgery 1Practice Guidelines as Topic 1Nivolumab 1Neoadjuvant Therapy 1Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Hypopharyngeal Neoplasms × Docetaxel × Clear all
NCT05494190 2025-12-30

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Eye & ENT Hospital of Fudan University

Phase NA Recruiting
111 enrolled
Head & Neck

Hypopharyngeal Neoplasms

NCT06611137 2024-09-26

SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx

Sun Yat-sen University

Phase 2 Recruiting
35 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡